These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37087801)

  • 21. LINC01278 Induces Autophagy to Inhibit Tumour Progression by Suppressing the mTOR Signalling Pathway.
    Liu B; Yao X; Zhang C; Li W; Wang Y; Liao Q; Li Z; Huang Q; Zhang Y; Wu W
    Oxid Med Cell Longev; 2023; 2023():8994901. PubMed ID: 36713034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy.
    Qin Y; Bollin K; de Macedo MP; Carapeto F; Kim KB; Roszik J; Wani KM; Reuben A; Reddy ST; Williams MD; Tetzlaff MT; Wang WL; Gombos DS; Esmaeli B; Lazar AJ; Hwu P; Patel SP
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33203661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy.
    Zhang XY; Zhang M; Cong Q; Zhang MX; Zhang MY; Lu YY; Xu CJ
    Int J Biochem Cell Biol; 2018 Feb; 95():9-16. PubMed ID: 29247711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma
    Zhou J; Jin B; Jin Y; Liu Y; Pan J
    Theranostics; 2017; 7(6):1447-1462. PubMed ID: 28529629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA‑22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
    Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Xue HQ; Sun L; Sun C; Feng W; Guo SB
    Oncol Rep; 2020 Apr; 43(4):1169-1186. PubMed ID: 32323781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PHA665752 inhibits the HGF-stimulated migration and invasion of cells by blocking PI3K/AKT pathway in uveal melanoma.
    Wang Z; He C; Liu L; Ma N; Chen X; Zheng D; Qiu GH
    Neoplasma; 2017; 64(3):377-388. PubMed ID: 28253717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Long-term Serial Passaging on the Characteristics and Properties of Cell Lines Derived From Uveal Melanoma Primary Tumors.
    Mouriaux F; Zaniolo K; Bergeron MA; Weidmann C; De La Fouchardière A; Fournier F; Droit A; Morcos MW; Landreville S; Guérin SL
    Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5288-5301. PubMed ID: 27723895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monosomy 3 Is Linked to Resistance to MEK Inhibitors in Uveal Melanoma.
    Mergener S; Siveke JT; Peña-Llopis S
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Up-regulation of microRNA miR-101-3p enhances sensitivity to cisplatin via regulation of small interfering RNA (siRNA) Anti-human AGT4D and autophagy in non-small-cell lung carcinoma (NSCLC).
    Cui D; Feng Y; Qian R
    Bioengineered; 2021 Dec; 12(1):8435-8446. PubMed ID: 34694211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arylsulfonamide 64B Inhibits Hypoxia/HIF-Induced Expression of c-Met and CXCR4 and Reduces Primary Tumor Growth and Metastasis of Uveal Melanoma.
    Dong L; You S; Zhang Q; Osuka S; Devi NS; Kaluz S; Ferguson JH; Yang H; Chen G; Wang B; Grossniklaus HE; Van Meir EG
    Clin Cancer Res; 2019 Apr; 25(7):2206-2218. PubMed ID: 30563937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pristimerin attenuates cell proliferation of uveal melanoma cells by inhibiting insulin-like growth factor-1 receptor and its downstream pathways.
    Xie X; Xie S; Xie C; Fang Y; Li Z; Wang R; Jiang W
    J Cell Mol Med; 2019 Nov; 23(11):7545-7553. PubMed ID: 31508890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-181a suppresses autophagy and sensitizes gastric cancer cells to cisplatin.
    Zhao J; Nie Y; Wang H; Lin Y
    Gene; 2016 Feb; 576(2 Pt 2):828-33. PubMed ID: 26589846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural withanolide withaferin A induces apoptosis in uveal melanoma cells by suppression of Akt and c-MET activation.
    Samadi AK; Cohen SM; Mukerji R; Chaguturu V; Zhang X; Timmermann BN; Cohen MS; Person EA
    Tumour Biol; 2012 Aug; 33(4):1179-89. PubMed ID: 22477711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-blockers exert potent anti-tumor effects in cutaneous and uveal melanoma.
    Bustamante P; Miyamoto D; Goyeneche A; de Alba Graue PG; Jin E; Tsering T; Dias AB; Burnier MN; Burnier JV
    Cancer Med; 2019 Dec; 8(17):7265-7277. PubMed ID: 31588689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.
    Landreville S; Agapova OA; Matatall KA; Kneass ZT; Onken MD; Lee RS; Bowcock AM; Harbour JW
    Clin Cancer Res; 2012 Jan; 18(2):408-16. PubMed ID: 22038994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of CD133 Overcomes Cisplatin Resistance Through Inhibiting PI3K/AKT/mTOR Signaling Pathway and Autophagy in CD133-Positive Gastric Cancer Cells.
    Lu R; Zhao G; Yang Y; Jiang Z; Cai J; Hu H
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819864311. PubMed ID: 31405336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CerS6 regulates cisplatin resistance in oral squamous cell carcinoma by altering mitochondrial fission and autophagy.
    Li S; Wu Y; Ding Y; Yu M; Ai Z
    J Cell Physiol; 2018 Dec; 233(12):9416-9425. PubMed ID: 30054909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo anti-uveal melanoma activity of JSL-1, a novel HDAC inhibitor.
    Wang Y; Liu M; Jin Y; Jiang S; Pan J
    Cancer Lett; 2017 Aug; 400():47-60. PubMed ID: 28455241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of resistance to imatinib mesylate in KIT-positive metastatic uveal melanoma.
    Calipel A; Landreville S; De La Fouchardière A; Mascarelli F; Rivoire M; Penel N; Mouriaux F
    Clin Exp Metastasis; 2014 Jun; 31(5):553-64. PubMed ID: 24652072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting primary and metastatic uveal melanoma with a G protein inhibitor.
    Onken MD; Makepeace CM; Kaltenbronn KM; Choi J; Hernandez-Aya L; Weilbaecher KN; Piggott KD; Rao PK; Yuede CM; Dixon AJ; Osei-Owusu P; Cooper JA; Blumer KJ
    J Biol Chem; 2021; 296():100403. PubMed ID: 33577798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.